Ultragenyx pharmaceutical inc.

Major-Pharmaceuticals

RARE


60 Leveroni Court
Novato , CA 94949

Executive/
Director

Price

  • Last Close
  • $ 41.46
    $ +0.34 0.83 %
    Jan 3, 2025
  • 52-Week High/Low
  • $57.77 - $31.73
  • YTD
  • -1.4%

  • Trading Volume
  • 40,304
  • Market Cap Full
  • $ 3.4B
  • Shares Outstanding
  • 82.1M
    Oct 30, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -43.6% -3.6% 9.9% 59.5% -5% -17.8% -13.1% -13.5% -2.4% -1.4%
Q2 -22.8% -8.4% 55.7% -11% 4% -16.3% -18.4% 15% -11.9% -
Q3 45% -14.3% -2.5% -31.4% 8% -7.9% -30.6% -22.7% 26.6% -
Q4 -0.9% -19.1% -43.1% -0.4% 68.4% -4.3% 11.9% 37.4% -15% -
J F M A M J J A S O N D
2025 -1.4% - - - - - - - - - - -
2024 -7.8% 17.3% -9.8% -9.2% -5.3% 3.2% 8.7% 26.6% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    156%-37%-34%-6%-2%223%-39%-45%3%-12%-1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.35 1.63 0.62 -1.82 -2.05 -2.03 -2.19 -2.33
Q2 1.46 1.72 -1.06 -1.72 0.41 -1.81 -2.26 -2.25
Q3 1.64 1.87 -1.74 -1.96 -1.13 -1.08 -3.5 -2.23
Q4 1.75 2.27 -1.79 -1.62 -0.3 -1.78 -2.17 -
A 6.2 7.5 -4 -7.1 -3.1 -6.7 -10.1 -6.81

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 51.3 57.9 66.9 69.4 70.2
Jun 49.8 57.5 59.7 67.5 69.9 70.8
Sep 50.2 57.7 60.6 67.8 70 71.5
Dec 50.6 57.8 61 68.2 70.1 82.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1 1 0.5 0.8 0.1
Fixed Asset Turnover 0.8 0.8 1.1 1.3 2.2
Total Asset Turnover 0.2 0.2 0.2 0.1 0.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -11.2 -5.3 2.3 20.2 2.1
Equity multiplier 1.2 0.5 0.2 0.1 -